SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001516551-24-000018
Filing Date
2024-03-04
Accepted
2024-03-04 06:17:54
Documents
2
Period of Report
2024-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1709551066.html 3  
1 FORM 3 wk-form3_1709551066.xml 3 1678
2 EX-24 a240229_skyextdxpoa.htm EX-24 5926
  Complete submission text file 0001516551-24-000018.txt   9341
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11250 EL CAMINO REAL SUITE 100 SAN DIEGO CA 92130
Business Address
Diep Tuan Tu (Reporting) CIK: 0002013809 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55136 | Film No.: 24712774